加味逍遥散治疗胸痹心痛临床观察  

Clinical Observation on Modified Xiaoyao/san in Treatment of Chest Pain

作　　者：马影蕊[1] 

机构地区：[1]辽宁中医药大学附属医院,辽宁沈阳110032

出　　处：《中华中医药学刊》2015年第6期1486-1488,共3页Chinese Archives of Traditional Chinese Medicine

摘　　要：目的:观察加味逍遥散治疗肝郁脾虚证胸痹心痛(冠心病心绞痛)的临床疗效。方法:采用对照、随机的原则将胸痹心痛证的患者分为对照组和治疗组各30例,两组患者均应用西医常规治疗,治疗组同时给予加味逍遥散口服汤剂,3周为1个疗程,观察患者临床症状、体征、心电图的改善情况。结果:治疗后试验组在治疗效果(93.3%vs80%),治疗前后主要症状单项积分变化比较,硝酸甘油使用情况及心绞痛疗效(90%vs73.3%)改善方面优于对照组,差异均有统计学意义(P<0.05);两组间在心电图疗效比较(50%vs46.67%)差异无统计学意义(P>0.05)。结论:加味逍遥散对胸痹心痛(冠心病心绞痛)疗效确切。Objective：To observe the modified Xiaoyao/san treating liver stagnation and spleen deficiency syndrome of chest pain （ angina pectoris） clinical curative effect. Methods ： by using the control, random principle will chest pain syn- drome patients were divided into control group and treatment group with 30 cases in each group. The application of con- ventional western medicine treatment was in two groups, the treatment group added the modified Xiaoyao/san oral decoc- tion,3 weeks as 1 course of treatment, hnprovement of the situation was observed in patients with clinical symptoms and signs. Results： After the treatment, the experimental group in the treatment effect before and after treatment （93.3% vs80% ） ,the main single symptom integral comparison of changes （efficacy and angina pectoris （90% vs73.3% ） was better than that of the control group, the difference was statistically significant （P 〈 0.05） ; between the two groups in the ECG efficacy （ 50% vs 46.67% ） there was no significant difference （ P 〉 0.05 ）. Conclusion ： The modified Xiaoyao/san on chest pain （angina pectoris） has curative effect.

关 键 词：加味逍遥散 胸痹心痛 临床观察 

分 类 号：R541.4[医药卫生—心血管疾病]